All attending UK organisations

UK companies attending UK @BIO-Europe 2018 as part of the official delegation

(Click here to search profiles):

UK Exhibitors
BioPartner UK: UK stand, booth #39
Abzena, Cello Health, Cobra Biologics, Evaluate, Fujifilm Diosynth, GlobalData, Life Sciences in the Northern Powerhouse, NIHR, PharmaIntelligence, SGS Vitrology, SQN Clinical, Symbiosis.

Life Sciences in the Northern Powerhouse:
Aptus Clinical, Bionow, Invest Liverpool, Peak Proteins  

UK stand (booth 39):
Alacrita Holdings, Alderley Park, Arcinova, Centre of Excellence in Infectious Diseases Research, Clinical Network Services (UK), Conversis, Crystec, GTN, High Force Research, IAG, Inivata, Intract Pharma, Karma Oncology, LSX, Medherant, Nanna Therapeutics, National Institute for Health Research (NIHR), OxStem, Scottish Development International, Therakind.

Other UK companies associated with the delegation*:
ALSA Holdings, AMR Centre, BioIndustry Association (BIA), Biorelate, Cello Health Consulting, CIMYM BioSciences, Circassia Pharmaceuticals, Clinical Accelerator, COLLAGEN SOLUTIONS, Colliers International Property, Concept Life Sciences, Curileum Discovery, Cypralis, Diamond Biopharm, Enesi Pharma, ERA Consulting UK, e-therapeutics, Evotec AG, Exploristics, Fusion Antibodies, Global Regulatory Services, HC Pharma Consultancy, HungaroTrial, Illetrop, Instinctif Partners, J A Kemp, metaLinear, Mironid, N4 Pharma, OBN, One Nucleus, Oppilotech, Precision for Medicine,  Oncology and Rare Disease, ProImmune, Quay Pharmaceuticals, Redx Pharma, Renovos Biologics, Sareum, SBA, scientistcom, Sekisui, Sygnature Discovery, SYNthesis Research, Tissue Solutions, UCB, VHsquared, Xenogesis.

UK Presenting companies:
Curileum Discovery, Cypralis, Exscientia, GTN, LIfT Biosciences, Lycotec, MiNA Therapeutics.

All attending UK companies:
3M United Kingdom, AbbVie, Abcam, Abingworth, Abzena, Aigenpulse, Akari Therapeutics, Alacrita Holdings, Albumedix, Alderley Park, Almac Discovery, Alpha Blue Ocean, Alpharmaxim, ALSA Holdings, AMR Centre, Apex Healthcare Consulting, Apitope Technology, Apollo Therapeutics, Aptus Clinical, Arcinova, Arix Bioscience Holdings, Arnold & Porter Kaye Scholer, ARTIOS PHARMA, Astellas Pharma Europe, AstraZeneca, Atelix, Athena Market Access Solutions, Atrium Court, AURUM Biosciences, Autolus, Avacta Life Sciences, Barrington James, Bayer UK, BenevolentAI, BG advisors, BioIndustry Association (BIA), BioPartner UK, Biopharma Group, Biorelate, Bioscience Pharma Partners, BiVictriX Therapeutics, Boult Wade Tennant, Bristows, Camena Bioscience, Cancer Research UK, Celerion, Cello Health Consulting, Centauri Therapeutics, Centre of Excellence in Infectious Diseases Research, Chugai Pharmaceutical Co,, CIMYM BioSciences, Circassia Pharmaceuticals, Clarivate Analytics, Clinical Accelerator, Clinical Network Services (UK), Clinigen Group, CN Bio Innovations, Cobra Biologics, COLLAGEN SOLUTIONS, Colliers International Property, Concept Life Sciences, Confluence Tax, Consilient Health, Conversis, Coulter Partners, Covance / Chiltern, Crescendo Biologics, Crystec, Curileum Discovery, Cypralis, DataArt Technologies UK, David Harrison - Business Development Consultant, Decision Resources Group, Destiny Pharma, Diamond Biopharm, Diurnal Group, DJS Antibodies, Drug Discovery Unit, University of Dundee, EBD Academy, EBD Group, Edinburgh Innovations, Edison, Eisai Co,, Eli Lilly, Embera NeuroTherapeutics, Enesi Pharma, Epidarex Capital Management, ERA Consulting UK, e-therapeutics, Ethypharm, EUSA Pharma, Evaluate, Evotec AG, Evotec UK, Expedeon, Exploristics, Exscientia, Ferghana Partners, Fieldfisher, F-star Biotechnology, FUJIFILM Diosynth Biotechnologies, Fusion Antibodies, Galen, GE Healthcare, Global Regulatory Services, GlobalData, Gowling WLG (UK), Greenhill, GTN, HC Pharma Consultancy, Health and Care Research Wales, Heptares Therapeutics, High Force Research, Horizon Discovery, HungaroTrial, IAG, ideaPoint, Iksuda Therapeutics, Illetrop, ImmuPharma, Inceptua GmbH, Informa/Scrip, Inivata, Instinctif Partners, Intract Pharma, Invest Liverpool, IONTAS, IP Group, IpI media world, IQVIA, IQVIA - Global Market Insights, Isogenica, J A Kemp, Johnson & Johnson Innovation, Karma Oncology, Karus Therapeutics, Kymab, Kyowa Kirin International, lamellar biomedical, Latham & Watkins, Life Sciences in the Northern Powerhouse (Bionow), LifeArc, Lifescience Industry, LIfT BioSciences, LightOx, Locust Walk, Lonza Pharma & Biotech, LSX, Lycotec, Macrophage Pharma, Mallinckrodt Pharmaceuticals, Mawdsleys, Medherant, Mediatum Development GmbH, Medicilon UK/EU Office - Link China Pharma, MEDICXI, Medifood, MedImmune, Medius Associates, MedPharm, Merck KGaA, Mereo BioPharma, metaLinear, Metrion Biosciences, Microbiotica, Midatech Pharma, Mills & Reeve, MiNA Therapeutics, Mironid, Mission Therapeutics, Mitra Biotech, Mitsubishi Tanabe Pharma, MSD, Mundipharma International, N4 Pharma, Nanna Therapeutics, NANOGAP Therapeutics, NANOGENICS, Nanomerics, National Institute for Health Research (NIHR), Nature Research, NDA Regulatory Service GmbH, Neem Biotech, Newcastle University / NIHR Innovation Observatory, Norgine Ventures, OBN UK, One Nucleus, Ono Pharma, Oppilotech, Orbit Discovery, Ossianix, Otsuka Pharmaceutical Company, Oval Medical Technologies, Oxford BioMedica, OxStem, Oxyrane, PAREXEL International, Patheon, part of Thermo Fisher Scientific, Peak Proteins, PeproTech, Pfizer, Pharmalicensing, PharmaVentures, Piramal Pharma Solutions, Planet Pharma Staffing, Plexus Ventures, Potter Clarkson, PPD, Precision for Medicine, Oncology and Rare Disease, Premier Research, ProAxsis, Procarta Biosystems, ProImmune, Prokarium, PsiOxus Therapeutics, Q2 Solutions, Quay Pharmaceuticals, Queen's University Belfast, RBW Consulting, Redx Pharma, Renovos Biologics, Rephine, Results Healthcare, ReViral, Rosemont Pharmaceuticals, Samedan, Sanofi, Sareum, Sartorius Stedim BioOutsource, SBA, Scancell, scientistcom, Scius Communications, Scottish Development International, SEC Recruitment, Sekisui, SGS Vitrology, Sidley Austin, Silence Therapeutics, Silicon Valley Bank, Simbec-Orion, Simcere Pharmaceutical Group, SiSaf, Skills Alliance Pharma, SLA Pharma, SmartAnalyst Inc, Solid Form Solutions - Avista Pharma, Springer Nature, SQN Clinical, Storm Therapeutics, Summit Therapeutics, Swedish Orphan Biovitrum, Sygnature Discovery, Symbiosis Pharmaceutical Services, Syneos Health, Synpromics, SYNthesis Research, Takeda, Taylor Wessing, TCRS, Teijin Pharma, Teva Pharmaceuticals, The Fulford Group, The RSA Group, The Sage Group, Theolytics, Therakind, Tissue Solutions, Tolley Health Economics, Torreya, Treehill Partners, Treos Bio, Ubiquigent, UCB Pharma, Ulster University, University of Bristol, University of Glasgow Stratified Medicine, Utility Therapeutics, VHsquared, VirdisGroup, Voisin Consulting Life Sciences (VCLS), Vygoris, West Pharmaceutical Services, Wildwood Ventures / Current Partnering, World Child Cancer, WuXi AppTec, WuXi Biologics, Xenogesis, Ximbio. (289)

 

Join them here!